Prothena Management
Management Kriterienprüfungen 2/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Gene Kinney
Geschäftsführender
US$7.0m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 9.0% |
| Amtszeit als Geschäftsführer | 8yrs |
| Eigentum des Geschäftsführers | 0.02% |
| Durchschnittliche Amtszeit des Managements | 7.5yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 5yrs |
Jüngste Management Updates
Recent updates
Unpleasant Surprises Could Be In Store For Prothena Corporation plc's (NASDAQ:PRTA) Shares
Jul 26
Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Jun 19Prothena: Potential For Future Price Drop On Failure Risk Of Late-Stage Trials
Jun 07New Forecasts: Here's What Analysts Think The Future Holds For Prothena Corporation plc (NASDAQ:PRTA)
May 14Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
Feb 23Investors Don't See Light At End Of Prothena Corporation plc's (NASDAQ:PRTA) Tunnel And Push Stock Down 33%
Feb 08Are Investors Undervaluing Prothena Corporation plc (NASDAQ:PRTA) By 32%?
Dec 20Prothena (NASDAQ:PRTA) Is In A Strong Position To Grow Its Business
Nov 24Prothena Corporation plc's (NASDAQ:PRTA) 29% Share Price Plunge Could Signal Some Risk
Oct 27Companies Like Prothena (NASDAQ:PRTA) Are In A Position To Invest In Growth
Aug 25What You Need To Know About The Prothena Corporation plc (NASDAQ:PRTA) Analyst Downgrade Today
May 10We Think Prothena (NASDAQ:PRTA) Can Easily Afford To Drive Business Growth
Apr 23Time To Worry? Analysts Just Downgraded Their Prothena Corporation plc (NASDAQ:PRTA) Outlook
Mar 01We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
Dec 28Prothena: Paying A Premium To Cover All The Alzheimer's Bases
Sep 29Prothena GAAP EPS of -$0.88 misses by $0.31
Aug 08Bearish: Analysts Just Cut Their Prothena Corporation plc (NASDAQ:PRTA) Revenue and EPS estimates
May 08Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$51m |
| Mar 31 2024 | n/a | n/a | -US$172m |
| Dec 31 2023 | US$7m | US$631k | -US$147m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$141m |
| Mar 31 2023 | n/a | n/a | -US$128m |
| Dec 31 2022 | US$7m | US$601k | -US$117m |
| Sep 30 2022 | n/a | n/a | -US$156m |
| Jun 30 2022 | n/a | n/a | -US$1m |
| Mar 31 2022 | n/a | n/a | US$67m |
| Dec 31 2021 | US$5m | US$573k | US$67m |
| Sep 30 2021 | n/a | n/a | US$69m |
| Jun 30 2021 | n/a | n/a | -US$70m |
| Mar 31 2021 | n/a | n/a | -US$124m |
| Dec 31 2020 | US$3m | US$554k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$102m |
| Jun 30 2020 | n/a | n/a | -US$91m |
| Mar 31 2020 | n/a | n/a | -US$80m |
| Dec 31 2019 | US$3m | US$538k | -US$78m |
| Sep 30 2019 | n/a | n/a | -US$79m |
| Jun 30 2019 | n/a | n/a | -US$84m |
| Mar 31 2019 | n/a | n/a | -US$128m |
| Dec 31 2018 | US$11m | US$525k | -US$156m |
| Sep 30 2018 | n/a | n/a | -US$181m |
| Jun 30 2018 | n/a | n/a | -US$209m |
| Mar 31 2018 | n/a | n/a | -US$167m |
| Dec 31 2017 | US$5m | US$521k | -US$153m |
Vergütung im Vergleich zum Markt: GeneDie Gesamtvergütung ($USD7.04M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD3.30M).
Entschädigung vs. Einkommen: GeneDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
Geschäftsführer
Gene Kinney (55 yo)
8yrs
Amtszeit
US$7,043,826
Vergütung
Dr. Gene G. Kinney, Ph D., has been the Chief Executive Officer and President of Prothena Corporation plc since September 26, 2016 and October 3, 2016 respectively and served as its Chief Operating Officer...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| President | 8yrs | US$7.04m | 0.024% $ 257.7k | |
| CFO & Chief Strategy Officer | 11.5yrs | US$2.70m | 0.0060% $ 64.4k | |
| Chief Operating Officer | 2.9yrs | US$2.63m | 0% $ 0 | |
| Chief Regulatory Officer | 7.8yrs | US$2.57m | 0% $ 0 | |
| Chief Medical Officer | 3.4yrs | US$2.68m | 0% $ 0 | |
| Chief Accounting Officer & Controller | 11.3yrs | keine Daten | keine Daten | |
| Chief Scientific Officer | 7.3yrs | US$3.34m | keine Daten | |
| Vice President of Investor Relations | no data | keine Daten | keine Daten | |
| Chief Legal Officer | no data | US$1.18m | keine Daten | |
| Chief People Officer | less than a year | keine Daten | keine Daten | |
| Company Secretary | no data | keine Daten | keine Daten |
7.5yrs
Durchschnittliche Betriebszugehörigkeit
55yo
Durchschnittliches Alter
Erfahrenes Management: PRTADas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (7.4 ).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| President | 8yrs | US$7.04m | 0.024% $ 257.7k | |
| Independent Director | 2.1yrs | US$896.63k | 0% $ 0 | |
| Independent Director | 11.8yrs | US$912.48k | 0.0023% $ 24.6k | |
| Independent Chairman | less than a year | keine Daten | keine Daten | |
| Independent Chair Emeritus | less than a year | US$923.48k | 0.00045% $ 4.9k | |
| Independent Director | 11.8yrs | US$917.26k | 0% $ 0 | |
| Independent Director | 11.2yrs | US$901.73k | 0.0078% $ 84.7k | |
| Independent Director | 5.2yrs | US$908.48k | 0% $ 0 | |
| Independent Director | 4.8yrs | keine Daten | keine Daten | |
| Independent Director | 1.3yrs | US$1.70m | keine Daten |
5.0yrs
Durchschnittliche Betriebszugehörigkeit
62yo
Durchschnittliches Alter
Erfahrener Vorstand: PRTADie Vorstandsmitglieder gelten als erfahren (4.9 Jahre durchschnittliche Amtszeit).